Ionis Pharmaceuticals (IONS) Capital Expenditures Growth (3y) (2012 - 2026)
Powered by 
Analysis
Ionis Pharmaceuticals (IONS) Capital Expenditures Growth (3y) (2012 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 23.48% |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 63.07% |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -45.93% |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | -40.95% |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 29.63% |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 60.74% |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 27.08% |
| 10 | Ionis Pharmaceuticals | 9.60 Bn | 7.55 Bn | 265.21 Mn | 10.21% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 10.21% |
| Mar 31, 2026 | 27.61% |
| Dec 31, 2025 | 72.63% |
| Sep 30, 2025 | -1.66% |
| Jun 30, 2025 | 54.52% |
| Mar 31, 2025 | 66.91% |
| Dec 31, 2024 | 116.80% |
| Sep 30, 2024 | 39.68% |
| Jun 30, 2024 | 12.67% |
| Mar 31, 2024 | 36.36% |
| Dec 31, 2023 | -29.25% |
| Sep 30, 2023 | -43.38% |
| Jun 30, 2023 | 9.70% |
| Mar 31, 2023 | 4.87% |
| Dec 31, 2022 | -18.91% |
| Sep 30, 2022 | -29.62% |
| Jun 30, 2022 | -5.99% |
| Mar 31, 2022 | -5.73% |
| Dec 31, 2021 | 21.73% |
| Sep 30, 2021 | 0.81% |